Schroder Investment Management Group’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.1M Sell
1,477,494
-802,047
-35% -$11.7M 0.02% 513
2025
Q4
$30.4M Sell
2,279,541
-187,588
-8% -$2.74M 0.02% 418
2025
Q3
$38.6M Sell
2,467,129
-112,220
-4% -$1.85M 0.03% 371
2025
Q2
$38.8M Sell
2,579,349
-264,164
-9% -$3.86M 0.03% 360
2025
Q1
$43.4M Buy
2,843,513
+74,572
+3% +$1.1M 0.04% 315
2024
Q4
$39.8M Sell
2,768,941
-154,726
-5% -$2.76M 0.04% 357
2024
Q3
$55.7M Sell
2,923,667
-100,670
-3% -$1.82M 0.06% 273
2024
Q2
$51.8M Sell
3,024,337
-825,456
-21% -$15.2M 0.06% 274
2024
Q1
$64.7M Sell
3,849,793
-330,043
-8% -$5.01M 0.08% 232
2023
Q4
$75.7M Sell
4,179,836
-39,332
-0.9% -$715K 0.1% 196
2023
Q3
$71.5M Sell
4,219,168
-383,503
-8% -$5.49M 0.11% 187
2023
Q2
$55.2M Buy
4,602,671
+34,307
+0.8% +$468K 0.08% 249
2023
Q1
$59.5M Sell
4,568,364
-88,420
-2% -$1.45M 0.09% 230
2022
Q4
$68.8M Buy
4,656,784
+316,388
+7% +$3.46M 0.11% 194
2022
Q3
$38.5M Buy
4,340,396
+855,777
+25% +$10.8M 0.06% 297
2022
Q2
$44M Buy
3,484,619
+74,492
+2% +$948K 0.07% 280
2022
Q1
$67.5M Buy
3,410,127
+308,084
+10% +$7.84M 0.09% 225
2021
Q4
$21.8M Buy
3,102,043
+71,992
+2% +$2.34M 0.03% 452
2021
Q3
$22.2M Buy
3,030,051
+1,930,312
+176% +$75.9M 0.03% 460
2021
Q2
$43.2M Sell
1,099,739
-2,915,949
-73% -$84.2M 0.05% 338
2021
Q1
$113M Buy
4,015,688
+99,643
+3% +$3.18M 0.15% 129
2020
Q4
$125M Buy
3,916,045
+104,791
+3% +$3.22M 0.18% 107
2020
Q3
$122M Sell
3,811,254
-237,138
-6% -$7.39M 0.19% 105
2020
Q2
$112M Buy
4,048,392
+64,482
+2% +$1.4M 0.2% 105
2020
Q1
$72.8M Buy
3,983,910
+1,285,243
+48% +$31M 0.16% 137
2019
Q4
$67.7M Buy
2,698,667
+354,022
+15% +$7.75M 0.11% 214
2019
Q3
$42.1M Buy
2,344,645
+714,434
+44% +$14.9M 0.07% 297
2019
Q2
$35.9M Sell
1,630,211
-219,813
-12% -$6.27M 0.07% 315
2019
Q1
$56.6M Buy
1,850,024
+46,069
+3% +$1.15M 0.1% 226
2018
Q4
$41.7K Hold
1,803,955
0.08% 279
2018
Q3
$58.1M Buy
1,803,955
+288,315
+19% +$8.79M 0.1% 243
2018
Q2
$46.3M Buy
1,515,640
+234,197
+18% +$7.44M 0.08% 284
2018
Q1
$37.9M Buy
1,281,443
+127,279
+11% +$4.53M 0.07% 327
2017
Q4
$45.5M Buy
1,154,164
+157,000
+16% +$5.02M 0.07% 309
2017
Q3
$27.2M Buy
997,164
+20,800
+2% +$511K 0.05% 414
2017
Q2
$22.7M Hold
976,364
0.04% 445
2017
Q1
$20.1M Buy
976,364
+62,045
+7% +$931K 0.04% 470
2016
Q4
$12.4M Buy
914,319
+289,776
+46% +$3.7M 0.02% 579
2016
Q3
$7.46M Buy
624,543
+208,006
+50% +$2.66M 0.01% 678
2016
Q2
$5.48M Buy
416,537
+87,485
+27% +$1.16M 0.01% 712
2016
Q1
$4.34M Buy
+329,052
New +$4.4M 0.01% 715

Other funds holding HCM

Schroder Investment Management Group's HCM Position: Q1 2026 in Review

Schroder Investment Management Group reduced its HUTCHMED (HCM) stake by 35% in Q1 2026, selling an estimated $11.7M and leaving 1,477,494 shares worth $22.1M. The position accounts for 0.02% of the portfolio, ranked #513.

Schroder Investment Management Group first reported a position in HCM in Q1 2016 and has held it in 41 quarters since. The position peaked at $125M in Q4 2020. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Schroder Investment Management Group held 1,477,494 shares of HUTCHMED worth $22.1M as of Q1 2026.
  • Schroder Investment Management Group sold 802,047 HUTCHMED shares in Q1 2026, an estimated $11.7M.
  • HUTCHMED made up 0.02% of Schroder Investment Management Group's portfolio in Q1 2026, its #513 holding.
  • Schroder Investment Management Group first reported a position in HUTCHMED in Q1 2016 and has held it in 41 quarters since.
  • Schroder Investment Management Group's HUTCHMED position peaked at $125M in Q4 2020.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.